Español
Español English Português 日本

In-person and livestream

Designed for Pediatric ERG

Learn from three clinicians in these in-person and live-streamed sessions

Join LKC Technologies for four SPECIAL sessions at AAPOS 2022 in Scottsdale, in-person AND live-streamed

Coming in person? Visit us at booth table #8!

Pediatric Ophthalmology is harnessing the power of ERG with unprecedented portability and non-invasive ease

In a pediatric setting, more than any other, ERG testing needs to be fast and easy on the patients, parents, and practitioners alike. Join us for these short in-person and online sessions. Learn from prominent clinicians who have integrated the handheld RETeval Device into their practices…and discovered that ERG testing is powerful, portable, and more versatile than ever.

Featuring:

Dr. Scott Atkinson, MD

Session 1: Integrating Handheld ERG with the RETeval into My Pediatric Clinic

Watch the Live Stream recording Below

scott atkinson pediatric ophthalmology erg
About Dr. Scott Atkinson

Dr. Rob Koenekoop MD, PhD

Session 2: From Babies on Laps to the ICU — ERG Testing on the go

Watch the Live Stream recording Below

pediatric ophthalmologist
About Dr. Rob Koenekoop

Ian M. MacDonald, MSc, MD CM

RETEval: An Evolution of Handheld ERG for Pediatrics

Watch the Live Stream recording Below

About Dr. Ian MacDonald

Special Live Demo: New Small-Sized Sensor Strips

Increased Versatility and Non-Invasive

Watch the Live Stream recording Below

Want to learn more about the RETeval?
Talk to Us!

cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2024 LKC Technologies, Inc.

Dr. Scott Charles Atkinson

scott atkinson pediatric ophthalmology erg
Dr. Scott Charles Atkinson is an ophthalmology specialist in Kansas City, MO. Dr. Atkinson completed a residency at University Of Pittsburgh Med Center. He currently practices at Children’s Mercy Hospital – Ophthalmology.

Dr. Robert K. Koenekoop, MD, PhD

pediatric ophthalmologist

Dr. Robert K. Koenekoop, MD, PhD, is Director of Pediatric Ophthalmology at the Montreal Children’s Hospital in Montreal, Quebec. A prominent researcher in genetic illnesses causing blindness, Dr. Koenekoop also serves as Associate Professor of Ophthalmology, McGill University and is Director at the McGill Ocular Genetics Laboratory. Dr. Koenekoop’s areas of expertise include Leber Congenital Amaurosis, Retinitis Pigmentosa, and other forms of blindness due to photoreceptor death in children. As he puts it himself, “I love my job, because I take care of children’s eyes and their vision, I do research to find new genes for blindness, and I am very fortunate to be involved in new treatments for blindness.”

Dr. Ian M. MacDonald

Dr. Ian M. MacDonald is a Professor of Ophthalmology and Visual Sciences at the University of Alberta, and past Chair. Dr. MacDonald completed residency training in Family Medicine at McGill University, Ophthalmology residency training at the University of Ottawa, and Clinical Genetics fellowship training at the University of Ottawa, Queen’s University, Kingston and the Hospital for Sick Children, Toronto. Dr. MacDonald is a member of the International Society for Genetic Eye Diseases & Retinoblastoma, the International Society for Clinical Electrophysiology and Vision. He is an Editor Emeritus for the Canadian Journal of Ophthalmology and currently serves on the Editorial Board of Survey of Ophthalmology for Genetics.

Dr. MacDonald has maintained continuous external grant funding throughout his career. His areas of interest are inherited retinal disorders, in particular, maculopathies and choroideremia. In 2009, in recognition of his work in Canada to foster the development of academic Ophthalmology, he was elected to as a Fellow of the Canadian Academy of Health Sciences.

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity